Introducing the Microbiome into Precision Medicine
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Understanding how individual people respond to medical therapy is a key facet of improving the odds ratio that interventions will have a positive impact. Reducing the non-responder rate for an intervention or reducing complications associated with a particular treatment or surgery is the next stage of medical advance. The Precision Medicine Initiative, launched in January 2015, set the stage for enhanced collaboration between researchers and medical professionals to develop next-generation techniques to aid patient treatment and recovery, and increased the opportunities for impactful pre-emptive care. The microbiome plays a crucial role in health and disease, as it influences endocrinology, physiology, and even neurology, altering the outcome of many different disease states, and it augments drug responses and tolerance. We review the implications of the microbiome on precision health initiatives and highlight excellent examples, whereby precision microbiome health has been implemented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 1×
“difficile colitis is known to be highly effective especially in recurrent infection [81]; however, this procedure still requires a licensed practitioner to have a protocol approved by their local Institutional Review Board, and therefore each patient needs to give consent prior to therapy.”
BackgroundGut biogeography of the bacterial microbiota
Donaldson, G. P., Lee, S. M., & Mazmanian, S. K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro3552 · Cited by 2,535 · cited 2×
“The microbiome is a complex, human coevolved ecosystem that produces many bioactive compounds, often for intercellular communication [26].”
BackgroundGut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460 · cited 1×
“How will the needs of different groups be best addressed across diets, lifestyles, and environments? What interventions will ultimately require social change rather than medical therapy, and what will the interplay between these fields be? genetics is a significant factor, such as in mental health disorders, incorpora…”
BackgroundThe Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Sender, R., Fuchs, S., & Milo, R. (2016) · Cell · doi:10.1016/j.cell.2016.01.013 · Cited by 2,050
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317 · cited 1×
“This has been realized at the multispecies level [57] through targeted inhibition of bacterial tri-methyl amine (TMA) formation by 3,3-dimethyl-1butanol (DMB, a structural analog of choline), ultimately attenuating atherosclerosis in a high choline diet mouse model.”
BackgroundMinireview: Gut microbiota: The neglected endocrine organ
Clarke, G., Stilling, R. M., Kennedy, P. J., Stanton, C., Cryan, J. F., & Dinan, T. G. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1108 · Cited by 1,192 · cited 2×
“Furthermore, alternative mechanisms for xenobiotic–microbiome interaction including immune [9,44,45] and endocrine [12] modulation by bacteria are known to exist, complicating and”
BackgroundBailey, M. T., Dowd, S. E., Galley, J. D., Hufnagle, A. R., Allen, R. G., & Lyte, M. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.023 · Cited by 1,123
Control of brain development, function, and behavior by the microbiome
Sampson, T. R., & Mazmanian, S. K. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.011 · Cited by 1,093 · cited 1×
“Certainly, the influences of the microbiome on our physiology are significant andmultitudinous, affecting immunology [9], neurology [10,11], endocrinology [12], and, importantly for precision medicine, disease states and clinical outcomes.”
BackgroundFat, fibre and cancer risk in African Americans and rural Africans
O’Keefe, S. J. D., Li, J. V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J. M., Kinross, J., Wahl, E., Ruder, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms7342 · Cited by 982
Xenobiotics shape the physiology and gene expression of the active human gut microbiome
Maurice, C. F., Haiser, H. J., & Turnbaugh, P. J. (2013) · Cell · doi:10.1016/j.cell.2012.10.052 · Cited by 811 · cited 1×
“Furthermore, these types of interactions are not limited to drugs classified as antibiotics; many other drugs have antibiotic and other microbial community structure and function modulating properties that are beginning to be appreciated [52,53].”
BackgroundEmerging molecular insights into the interaction between probiotics and the host intestinal mucosa
Bron, P. A., van Baarlen, P., & Kleerebezem, M. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2690 · Cited by 690 · cited 2×
“outcomes through multifarious means [71].”
BackgroundThe gastrointestinal microbiota as a site for the biotransformation of drugs
Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.009 · Cited by 618 · cited 2×
“Importantly, the primary forms of xenobiotic metabolism are different between human and bacterial cells: oxidation and conjugation dominate in the former case, reduction and hydrolysis in the latter [34].”
BackgroundCollective unconscious: How gut microbes shape human behavior
Dinan, T. G., Stilling, R. M., Stanton, C., & Cryan, J. F. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.021 · Cited by 571 · cited 1×
“Certainly, the influences of the microbiome on our physiology are significant andmultitudinous, affecting immunology [9], neurology [10,11], endocrinology [12], and, importantly for precision medicine, disease states and clinical outcomes.”
BackgroundPowell, L. M., Slater, S., Chaloupka, F. J., & Harper, D. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.065573 · Cited by 544
Precision oncology: an overview
Garraway, L. A., Verweij, J., & Ballman, K. V. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.4799 · Cited by 405
Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics
Carmody, R. N., & Turnbaugh, P. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72335 · Cited by 268 · cited 1×
“Currently, >60 drugs have been identified to have microbiome interactions according to the PharmacoMicrobiomics database [35], and given the vast number of possible uniquemicrobial metabolic transformations [36], many more interactions are likely to be discovered compared with the apparently limited number of human ge…”
BackgroundCategorization of the gut microbiota: enterotypes or gradients?
Jeffery, I. B., Claesson, M. J., O'Toole, P. W., & Shanahan, F. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2859 · Cited by 238 · cited 1×
“Evolution of microorganisms, horizontal transfer of genes, and subtleties in the characterization into types of microbiomes [24] make the microbiome snapshot style data often acquired a problem.”
BackgroundDavey, K. J., Cotter, P. D., O'Sullivan, O., Crispie, F., Dinan, T. G., Cryan, J. F., & O'Mahony, S. M. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.83 · Cited by 236
Developing a metagenomic view of xenobiotic metabolism
Haiser, H. J., & Turnbaugh, P. J. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.07.009 · Cited by 186 · cited 1×
“Digoxin has a narrow therapeutic window, and thus a wrong dosage could lead to significant toxicity, highlighting the need for further study of metagenomic diagnostics and insights to adverse outcomes [43].”
BackgroundPrecision-guided antimicrobial peptide as a targeted modulator of human microbial ecology
Guo, L., McLean, J. S., Yang, Y., Eckert, R., Kaplan, C. W., Kyme, P., Sheikh, O., Varnum, B., Lux, R., Shi, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506207112 · Cited by 172
Validating bifidobacterial species and subspecies identity in commercial probiotic products
Lewis, Z. T., Shani, G., Masarweh, C. F., Popovic, M., Frese, S. A., Sela, D. A., Underwood, M. A., & Mills, D. A. (2016) · Pediatric Research · doi:10.1038/pr.2015.244 · Cited by 154 · cited 1×
“The regulation and marketing of these treatments will at least pose challenges for traditional models [90,91], as evidenced by the current stance of the FDA on probiotics [92], which has led to faster product delivery to the public but also quality control and effectiveness issues [93].”
BackgroundTransfer of gut microbiota from lean and obese mice to antibiotic-treated mice
Ellekilde, M., Selfjord, E., Larsen, C. S., Jakesevic, M., Rune, I., Tranberg, B., Vogensen, F. K., Nielsen, D. S., Bahl, M. I., Licht, T. R., et al. (2014) · Scientific Reports · doi:10.1038/srep05922 · Cited by 153 · cited 1×
“In fact, studies of this nature already exist, both in humans [84] and especially in mice, where genetics can be well controlled [85].”
BackgroundProbiotics, prebiotics, and the host microbiome: the science of translation
Petschow, B., Doré, J., Hibberd, P., Dinan, T., Reid, G., Blaser, M., Cani, P. D., Degnan, F. H., Foster, J., Gibson, G., et al. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12303 · Cited by 124
Deciphering the tête-à-tête between the microbiota and the immune system
Surana, N. K., & Kasper, D. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72332 · Cited by 120 · cited 2×
“Furthermore, alternative mechanisms for xenobiotic–microbiome interaction including immune [9,44,45] and endocrine [12] modulation by bacteria are known to exist, complicating and”
Background
Cited by
Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
Liu, J., Tan, Y., Cheng, H., Zhang, D., Feng, W., & Peng, C. (2022) · Aging and disease · doi:10.14336/ad.2022.0104 · Cited by 529
“Because of their significance in health and disease, gut microbiota has become an important consideration in the way toward precision medicine [206].”
BackgroundGut microbiota and cardiovascular disease: opportunities and challenges
Kazemian, N., Mahmoudi, M., Halperin, F., Wu, J. C., & Pakpour, S. (2020) · Microbiome · doi:10.1186/s40168-020-00821-0 · Cited by 384
Advancing functional and translational microbiome research using meta-omics approaches
Zhang, X., Li, L., Butcher, J., Stintzi, A., & Figeys, D. (2019) · Microbiome · doi:10.1186/s40168-019-0767-6 · Cited by 340
Drug-microbiota interactions: an emerging priority for precision medicine
Zhao, Q., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 268
Coque, T. M., Cantón, R., Pérez-Cobas, A. E., Fernández-de-Bobadilla, M. D., & Baquero, F. (2023) · Microorganisms · doi:10.3390/microorganisms11041050 · Cited by 258
Metadata
- Authors
- Kuntz, T. M., & Gilbert, J. A.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 38
- Issue
- 1
- Pages
- 81-91
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2547512372
- Cited by
- 101
- References
- 26
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.